ARHGAP36: the arginine finger UniProt annotates, and the residue that is there

Every number below is produced by analyze_arhgap36.py in this directory.
Re-run it to regenerate this file; do not hand-edit.

uv run --no-project --with "biopython>=1.85" python analyze_arhgap36.py
uv run --no-project --with "biopython>=1.85" python analyze_arhgap36.py --self-test

1. What the UniProt entry says about itself

entry RHG36_HUMAN (Q6ZRI8), 547 aa
Rho-GAP DOMAIN 226..426
annotated arginine-finger Site 258
evidence on that Site ECO:0000255
residue actually at that position T
FUNCTION comment asserting GAP activity "GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state"
evidence on that comment ECO:0000250

The entry therefore annotates a catalytic arginine at 258 and carries T there, while asserting GTPase-activator activity on ECO:0000250. Both statements are rule- or similarity-derived; neither is experimental.

2. Is that Site in register?

A ProRule Site is placed by profile alignment and can be misplaced, so the position is re-derived from controls that carry their own annotated arginine finger. Each control's finger is projected onto ARHGAP36 Rho-GAP domain to Rho-GAP domain.

control entry its own site residue projects onto ARHGAP36 residue there same as ARHGAP36's own Site
Q07960 RHG01_HUMAN 282 R 258 T yes
O54834 RHG06_MOUSE 435 R 258 T yes
O43182 RHG06_HUMAN 433 R 258 T yes

Distinct positions the controls project onto: [258]. Unanimous: yes. Agrees with UniProt's own Site: yes.

Method control — every control projected onto every other control must recover a known arginine finger:

from to projected target's own site recovered residue
RHG01_HUMAN RHG06_MOUSE 435 435 yes R
RHG01_HUMAN RHG06_HUMAN 433 433 yes R
RHG06_MOUSE RHG01_HUMAN 282 282 yes R
RHG06_MOUSE RHG06_HUMAN 433 433 yes R
RHG06_HUMAN RHG01_HUMAN 282 282 yes R
RHG06_HUMAN RHG06_MOUSE 435 435 yes R

3. Could the arginine simply have moved?

The only result that would rescue the annotation is an arginine displaced by a residue or two. A window of ±10 residues around position 258 was scanned.

window 248..268
sequence KHGLSAVGIFTLEYSVQRVRQ
arginines in window [265, 267]
nearest arginine 265
offset from the annotated site 7

4. Does the sequence record agree with the published residue?

Three records name this residue in three different numberings. Rather than assume which isoform each belongs to, the site is recomputed under the canonical sequence and under every UniProt splice variant lying wholly upstream of it, and each published number is looked for among the results — against the record of the species that paper worked in.

4a. RHG36_HUMAN (Q6ZRI8), site 258

variant span description net offset position of the site residue isoform length
(canonical) — displayed sequence +0 258 T 547 aa
VSP_021357 1..136 in isoform 3 -136 122 T 411 aa
VSP_039235 1..48 in isoform 5 -48 210 T 499 aa
VSP_021358 1..32 in isoform 2 -31 227 ← T 516 aa
VSP_039236 1..31 in isoform 4 -12 246 T 535 aa

4b. RHG36_MOUSE (B1AUC7), site 246

variant span description net offset position of the site residue isoform length
(canonical) — displayed sequence +0 246 ← T 590 aa
VSP_039237 1..34 in isoform 3 -34 212 T 556 aa
VSP_039238 1..19 in isoform 2 -16 230 T 574 aa

Both published numberings fall out of the splice-variant arithmetic. The threonine call therefore rests on three records that could each have disagreed — a profile-based UniProt annotation and two papers' own construct numbering — and on none of them alone.

4c. Is the substitution shared with the mouse ortholog?

The IBD under review sits at PANTHER node PTN000973894, a Eumetazoa-level node. Whether the substitution is a human-lineage quirk or a property of the subfamily the node propagates into turns on whether the mouse ortholog shares it. Both proteins are in PANTHER subfamily PTHR12635:SF8.

human RHG36_HUMAN mouse RHG36_MOUSE
length 547 aa 590 aa
Rho-GAP DOMAIN 226..426 214..414
annotated arginine-finger Site 258 246
residue there T T

The ortholog's own Site is held to the same register test as the query's:

control projects onto mouse residue agrees with the mouse Site
RHG01_HUMAN 246 T yes
RHG06_MOUSE 246 T yes
RHG06_HUMAN 246 T yes

Human site 258 projects onto mouse position 246; mouse site 246 projects back onto human 258. Substitution shared: yes.

So the arginine was already gone in the last common ancestor of mouse and human — far below the Eumetazoan node the IBD is placed at, and therefore inside the clade that node propagates GO:0005096 into. The node placement, not the transfer mechanics, is what the review has to argue with.

5. Is the loss ARHGAP36's, or the family's?

role accession entry annotated site residue
PAINT/IBD seed (MGI:1196332) O54834 RHG06_MOUSE 435 R
human paralog, same PANTHER family O43182 RHG06_HUMAN 433 R
binds a RHO GTPase without catalysing (reference) Q01968 OCRL_HUMAN 757 Q
retains R but is experimentally GAP-dead Q3KRB8 RHGBB_HUMAN 87 R
query Q6ZRI8 RHG36_HUMAN 258 T

Across all reviewed human proteins carrying the PROSITE RhoGAP profile PS50238:

count
entries 66
with an annotated arginine finger 66
that position holds R 60
that position does not hold R 6

Entries whose annotated arginine-finger position does not hold an arginine:

entry residue
ARAP2_HUMAN Q
DEP1B_HUMAN I
FA13B_HUMAN Q
I5P2_HUMAN Q
OCRL_HUMAN Q
RHG36_HUMAN T

The query is among them: yes. The decoupling control (RHGBB_HUMAN) is not — it keeps its arginine and is nonetheless experimentally GAP-dead, so a retained arginine is not evidence of activity. The inference this report supports runs only in the other direction.

6. Catalysis versus binding

UniProt records an experimental RAC1 interaction via ARHGAP36's Rho-GAP domain. Losing the catalytic arginine does not by itself remove the binding surface, so the two are counted separately. The GAP:GTPase interface is taken from PDB 1TX4 (p50RhoGAP:RhoA:GDP:AlF4), as every GAP residue with an atom within 4.5 A of the GTPase or of the nucleotide/metal/fluoride.

Chain roles are proved, not assumed: chain A is 99.5% identical to Q07960 and chain B is 99.4% identical to P61586. The calculation recovers the control's own annotated arginine finger (282) among its contacts, as it must.

count
control GAP:GTPase contacts 25
inside the control's Rho-GAP domain 25
projected onto ARHGAP36 25
unmapped (aligned to a gap) 0
identical residue in ARHGAP36 8

Projection in register (control's finger lands on ARHGAP36's own Site 258): yes.

control pos control res ARHGAP36 pos ARHGAP36 res identical
278 E 254 V no
279 G 255 G yes
282 R 258 T no
283 R 259 L no
284 S 260 E no
285 A 261 Y no
286 N 262 S no
287 T 263 V no
288 Q 264 Q yes
309 N 285 Q no
319 K 295 K yes
323 R 299 R yes
386 K 373 R no
387 M 374 M yes
391 N 378 N yes
394 V 381 L no
395 V 382 V yes
398 P 385 S no
399 N 386 A no
406 A 397 E no
407 A 398 S no
409 T 400 K no
410 L 401 T no
413 I 409 V no
417 N 413 N yes

8 of 25 projected interface positions (32%) are identical in ARHGAP36. A percentage alone has no scale, so the same interface was projected onto RHG06_MOUSE (O54834), the PAINT/IBD seed, experimentally GAP-active — the member of this family whose experiments are the basis of the IBD under review. It scores 9/25 (36%).

So the GTPase-contacting surface is conserved in ARHGAP36 to a degree comparable to the family member that does catalyse, while the one residue that performs the catalysis is not conserved. That is the configuration in which a domain can still engage a GTPase without accelerating its hydrolysis — the shape OCRL_HUMAN is documented to have. This is a statement about what the structure permits, not a measurement of binding: the binding claim rests on the curated experiment, not on this table.